We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Thyroid Cancer and T Lymphoblastic Leukemia in Crohn Disease: A Case Report and Literature Review.
- Authors
Ja Min Byun; Sun Kyung Baek; Hwi-Joong Yoon; Si-Young Kim; Chi Hoon Maeng; Tae Sung Park; Hyo-Jong Kim; Yun Young Choi; Yu Jin Um
- Abstract
The effectiveness of the tumor necrosis--α (TNF-α) blockade has changed the treatment of several chronic inflammatory diseases, including inflammatory bowel disease; however, this treatment also has disadvantages. The use of immunosuppressants in combination with infliximab has been associated with greater risk of developing malignant neoplasms. Herein, we report the case of a 33-year-old ethnic Korean man with Crohn disease (CD) who developed papillary thyroid carcinoma (PTC) and, subsequently, T-cell acute lymphoblastic leukemia (ALL) after approximately 16.0 years of immunosuppressant therapy and 5.5 years of infliximab therapy. To our knowledge, this is the first case described in the literature of 2 different malignant neoplasms, 1 of hematologic origin and the other involving the solid organs, in a patient with CD. Through a systematic literature review, we found 28 cases of acute leukemia in adult patients with CD, of whom 22 had myeloid leukemia and 6 had lymphoid leukemia. Half of the patients with ALL underwent TNF-α--blocker therapy in combination with thiopurines.
- Subjects
ANTINEOPLASTIC agents; IMMUNOSUPPRESSIVE agents; INFLIXIMAB; CROHN'S disease; LYMPHOCYTIC leukemia; THYROID gland tumors; TREATMENT effectiveness
- Publication
Laboratory Medicine, 2015, Vol 46, Issue 2, p140
- ISSN
0007-5027
- Publication type
Article
- DOI
10.1309/LMU4KMJDRM3AD6FQ